Kuano Company
Kuano provides innovative quantum and AI solutions for drug discovery and design.
It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
Investors
.png)
Connections from
Total Funding:
3627438
Founded Date:
2020-01-01
Industry:
Quantum Biology
Employee Number:
11-50
Last Funding Date:
2023-09-12
Funding Status:
private
Headquarters:
London,England,United Kingdom,Europe
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
2800000
Last Funding Total Usd:
2248426
Last Funding Total Currency:
GBP
Last Funding Total Value:
1800000
Founders:
David Wright,Jarryl D'Oyley,Parminder Ruprah,Vid Stojevic